全文获取类型
收费全文 | 7452篇 |
免费 | 387篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 160篇 |
妇产科学 | 67篇 |
基础医学 | 1309篇 |
口腔科学 | 266篇 |
临床医学 | 508篇 |
内科学 | 1546篇 |
皮肤病学 | 229篇 |
神经病学 | 845篇 |
特种医学 | 449篇 |
外科学 | 997篇 |
综合类 | 43篇 |
一般理论 | 2篇 |
预防医学 | 267篇 |
眼科学 | 99篇 |
药学 | 555篇 |
中国医学 | 11篇 |
肿瘤学 | 491篇 |
出版年
2022年 | 36篇 |
2021年 | 61篇 |
2020年 | 72篇 |
2019年 | 91篇 |
2018年 | 113篇 |
2017年 | 97篇 |
2016年 | 111篇 |
2015年 | 154篇 |
2014年 | 242篇 |
2013年 | 294篇 |
2012年 | 396篇 |
2011年 | 417篇 |
2010年 | 305篇 |
2009年 | 286篇 |
2008年 | 427篇 |
2007年 | 475篇 |
2006年 | 477篇 |
2005年 | 496篇 |
2004年 | 469篇 |
2003年 | 488篇 |
2002年 | 495篇 |
2001年 | 98篇 |
2000年 | 87篇 |
1999年 | 134篇 |
1998年 | 130篇 |
1997年 | 100篇 |
1996年 | 88篇 |
1995年 | 78篇 |
1994年 | 71篇 |
1993年 | 57篇 |
1992年 | 56篇 |
1991年 | 52篇 |
1990年 | 44篇 |
1989年 | 39篇 |
1988年 | 33篇 |
1987年 | 56篇 |
1986年 | 31篇 |
1985年 | 44篇 |
1984年 | 30篇 |
1983年 | 33篇 |
1982年 | 41篇 |
1981年 | 34篇 |
1980年 | 36篇 |
1978年 | 38篇 |
1977年 | 30篇 |
1976年 | 40篇 |
1975年 | 27篇 |
1974年 | 40篇 |
1973年 | 31篇 |
1970年 | 30篇 |
排序方式: 共有7876条查询结果,搜索用时 0 毫秒
81.
Sonja Loges Gerhard Heil Melanie Bruweleit Volker Schoder Martin Butzal Uta Fischer Ursula M Gehling Gunter Schuch Dieter K Hossfeld Walter Fiedler 《Journal of clinical oncology》2005,23(6):1109-1117
PURPOSE: Bone marrow neoangiogenesis plays an important pathogenetic and possible prognostic role in acute myeloid leukemia (AML). Members of the vascular endothelial growth factor (VEGF) and angiopoietin family represent the most specific inducers of angiogenesis secreted by AML blasts. We therefore correlated expression of angiogenic factors with clinical variables. PATIENTS AND METHODS: We investigated the expression of VEGF-A, VEGF-C, angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), and the receptor Tie2 by quantitative polymerase chain reaction in a cohort of 90 patients younger than 61 years with de novo AML entered into the German AML Süddeutsche H?moblastose Gruppe Hannover 95 trial. Uni- and multivariate analyses were performed using clinical and gene expression variables. RESULTS: Univariate analysis of overall survival indicated the following variables as prognostic factors: good response on a day-15 bone marrow examination after initiation of induction chemotherapy, karyotype, and high Ang2 expression. In multivariate analysis, only bad response and log Ang2 expression remained of statistical significance, with a hazard ratio of 3.51 (95% CI, 1.91 to 6.47) and 0.75 (95% CI, 0.61 to 0.91), respectively. Subgroup analysis suggested that the prognostic impact of Ang2 expression was especially evident in cohorts with low VEGF-C and Ang1 mRNA levels. CONCLUSION: These results show that expression of Ang2 represents an independent prognostic factor in AML. Additional research into interactions of angiogenic cytokines in the pathogenesis of bone marrow angiogenesis in AML is warranted. 相似文献
82.
Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. 总被引:7,自引:0,他引:7
Lukas A Hefler Christoph Grimm Tilmann Lantzsch Dieter Lampe Sepp Leodolter Heinz Koelbl Georg Heinze Alexander Reinthaller Dan Tong-Cacsire Clemens Tempfer Robert Zeillinger 《Clinical cancer research》2005,11(16):5718-5721
PURPOSE: Genetic polymorphisms of cytokine-encoding genes are known to predispose to malignant disease. Interleukin (IL)-1 and IL-6 are crucially involved in breast carcinogenesis. Whether polymorphisms of the genes encoding IL-1 (IL1) and IL-6 (IL6) also influence breast cancer risk is unknown. EXPERIMENTAL DESIGN: In the present case-control study, we ascertained three polymorphisms of the IL1 gene cluster [-889 C/T polymorphism of the IL1alpha gene (IL1A), -511 C/T polymorphism of the IL1beta promoter (IL1B promoter), a polymorphism of IL1beta exon 5 (IL1B exon 5)], an 86-bp repeat in intron 2 of the IL1 receptor antagonist gene (IL1RN), and the -174 G/C polymorphism of the IL6 gene (IL6) in 269 patients with breast cancer and 227 healthy controls using PCR and pyrosequencing. RESULTS: Polymorphisms within the IL1 gene cluster and the respective haplotypes were not associated with the presence and the phenotype of breast cancer. The IL6 polymorphism was significantly associated with breast cancer. Odds ratios for women with one or two high-risk alleles versus women homozygous for the low-risk allele were 1.5 (95% confidence interval, 1.04-2.3; P = 0.04) and 2.0 (95% confidence interval, 1.1-3.6; P = 0.02), respectively. No association was ascertained between presence of the IL6 polymorphism and various clinicopathologic variables. CONCLUSIONS: Although polymorphisms within the IL1 gene cluster do not seem to influence breast cancer risk or phenotype, presence of the -174C IL6 allele increases the risk of breast cancer in Caucasian women in a dose-dependent fashion. 相似文献
83.
Michael Patrick Lux Sven Ackermann Mayada R Bani Caroline Nestle-Kr?mling Timm O Goecke Dieter Niederacher R Bodden-Heidrich Hans-Georg Bender Matthias Wilhelm Beckmann Peter Andreas Fasching 《European journal of cancer prevention》2005,14(6):503-511
INTRODUCTION: Some 5-10% of all cases of breast cancer and ovarian cancer have a hereditary genesis. In the setting of an interdisciplinary cancer genetics clinic, a study of the age at which patients first take advantage of early cancer detection (ECD) facilities was conducted in order to assess the influence of familial risk on health issues. METHODS: The study included 556 women who fulfilled the inclusion criteria (IC) for genetic analysis of the BRCA1 and BRCA2 genes, as well as 205 who did not meet these criteria but attended the primary consultation. RESULTS: Consulters who met the inclusion criteria took advantage of nearly all methods of ECD at an earlier time than women who did not. A comparison of consulters with or without breast cancer showed that those without breast cancer participated in all methods of ECD at an earlier time. CONCLUSION: Methods of improving and increasing participation in ECD facilities, and of encouraging women who are at risk to start on such programs at a younger age, need to be discussed. In this study, familial risk already resulted in a younger age of uptake of ECD facilities. 相似文献
84.
Maren Hedtke Rodrigo Pessoa Rejas Matthias F. Froelich Volker Ast Angelika Duda Laura Mirbach Victor Costina Uwe M. Martens RalfDieter Hofheinz Michael Neumaier Verena Haselmann 《Molecular oncology》2022,16(10):2042
The analysis of circulating tumor DNA (ctDNA) is at the threshold of implementation into standard care for colorectal cancer (CRC) patients. However, data about the clinical utility of liquid profiling (LP), its acceptance by clinicians, and its integration into clinical workflows in real‐world settings remain limited. Here, LP tests requested as part of routine care since 2016 were retrospectively evaluated. Results show restrained request behavior that improved moderately over time, as well as reliable diagnostic performance comparable to translational studies, with an overall agreement of 91.7%. Extremely low ctDNA levels at < 0.1% in over 20% of cases, a high frequency of concomitant driver mutations (in up to 14% of cases), and ctDNA levels reflecting the clinical course of disease were revealed. However, certain limitations hampering successful translation of ctDNA into clinical practice were uncovered, including the lack of clinically relevant ctDNA thresholds, appropriate time points of LP requests, and integrative evaluation of ctDNA, imaging, and clinical findings. In conclusion, these results highlight the potential clinical value of LP for CRC patient management and demonstrate issues that need to be addressed for successful long‐term implementation in clinical workflows. 相似文献
85.
86.
Summary When slices of rat dorsal caudatoputamen (= neostriatum) are incubated in vitro, Choecystokinin-like immunoreactivity (CCK-LI) is released upon addition of veratridine (3.75 mol/l). This release is affected by dopamine and by -aminobutyric acid (GABA)-receptor agonists. Dopamine enhances the release by stimulating dopamine D2-receptors and decreases it via D1-receptors. GABAA-receptor agonists enhance the veratridine-induced release of CCK-LI, while GABAB-receptor agonists decrease it. In the present investigation, it was examined whether GABA-receptors are involved in the effect which dopamine exerts via D2-receptors. The GABAA-receptor antagonist bicuculline (10 mol/l)and the blocker of the GABAA-receptor ionophore picrotoxin (1 mol/l) did not affect the dopamine (0.1 mol/1)-induced increase in the release of CCK-LI. However, the GABAA-receptor agonist muscimol (1 mol/l) not only enhanced the release of CCK-LI, but also prevented a further enhancement by dopamine (0.1 mol/l). This effect of muscimol was blocked by bicuculline (10 mol/l). In the presence of -amino-n-valeric acid (0.1 mmol/l), which has been described to block GABAB-receptors, dopamine no longer enhanced the veratridine-induced release of CCK-LI. -Amino-n-valeric acid also inhibited the pronounced enhancement of the release of CCK-LI caused by dopamine (0.1 mol/l) and 1 mol/l in the presence of the preferential D1-receptor antagonist SCH 23390. The effect of -amino-n-valeric acid persisted in the presence of bicuculline (10 mol/l and 100 mol/l). (+)-Baclofen, a partial agonist at GABAB-receptors, and the stereoisomer (–)-baclofen, a full agonist, also prevented the effect of dopamine on the veratridine-induced release of CCK-LI. The effects of both drugs may be due to desensitization of GABAB-receptors, which has been described to develop quite rapidly. It is concluded that -amino-n-valeric acid blocks GABAB-receptors and in this way prevents the enhancement of the veratridine-induced release of CCK-LI caused by dopamine via D2-receptors. These data are interpreted as evidence that dopamine and GABA-neurons can directly or indirectly interact in the rat neostriatum.
Send offprint requests to D. K. Meyer at the above address 相似文献
87.
PURPOSE: To assess, if a slow multifocal stimulus (mfS) can provoke a perfusion response that can be measured with the Retinal Vessel Analyzer (RVA). METHODS: Seventeen eyes were examined. Pupils were dilated. A 120-second baseline recording was obtained with the RVA. The subject then turned to view an mfS for 56 s. The mfS consisted of 103 hexagons flickering according to an m-sequence with a stimulus base interval of 53.3 ms (L(max) = 100 cd/m(2), L(min) < 1 cd/m(2)). Immediately thereafter, the subject turned to the RVA, where measurements were resumed as soon as the same retinal vessel was targeted and continued for 104 s. Stimulation and recording was repeated twice. The diameter of a retinal vein and artery was measured for a length of at least 1 mm. The maximum vessel response was obtained by linear interpolation of the measured response within the 20 s following mfS. RESULTS: On average, veins dilated by 6.8% and arteries by 7% following mfS (p > 0.005). Such a dilatation could be observed in 9 veins and 7 arteries. Three venous and 2 arterial measurements did not show a dilatation following mfS. However, 13 of 34 measurements could not be analyzed due to signal problems or because the time from the end of mfS and the uptake of measurement exceeded 20 s. CONCLUSION: This slow multifocal ERG stimulus results in a dilatation of arteries and veins that can be measured with the RVA. Coupling an mfS to the RVA has the potential to topographically map changes in retinal perfusion in relation to the respective retinal area stimulated. When implementing the mfS into the RVA setup in order not to lose time due to the refixation in the RVA following mfS, one is required to take the transient nature of this perfusion change into consideration. 相似文献
88.
Sørensen Rodewald Böhmig Sponholz H. Brach Orzechowski H. Hruszek Stelzer Mühlbock Stelzer Krauspe Werthemann Küster Haagen Hegemann W. Biedermann Fetscher Dieter Hintze H. Chantraine Engelmann Taeger H. Brach 《Journal of cancer research and clinical oncology》1940,49(1):44-53
Ohne Zusammenfassung 相似文献
89.
90.
Juliane Kager Jochen Schneider Sebastian Rasch Peter Herhaus Mareike Verbeek Carolin Mogler Albert Heim Gert Frsner Dieter Hoffmann Roland M. Schmid Tobias Lahmer 《Viruses》2022,14(7)
Human adenovirus (HAdV) can often lead to fulminant hepatitis in immunocompromised patients, mostly after reactivation of HAdV. Different risk factors, e.g., transplantation and chemotherapy, increase the risk of developing a HAdV hepatitis. We retrospectively analyzed three patients who showed the characteristics of a HAdV hepatitis observed in disseminated disease. In addition to PCR, diagnosis could be proven by pathology, CT scan, and markedly elevated transaminases. All patients had a hemato-oncologic underlying disease. Two had received a stem-cell transplant, and one was under chemotherapy including rituximab. Despite therapy with cidofovir, all patients died. As the incidence of HAdV hepatitis is low, diagnosis may be easily overlooked. No treatment approaches have yet been established. HAdV hepatitis should be considered as a differential diagnosis, especially when risk factors are present. To avoid dissemination, treatment should be initiated as soon as possible. 相似文献